About: The daily impact of COVID-19 in gastroenterology

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The daily impact of COVID-19 in gastroenterology Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	The daily impact of COVID-19 in gastroenterology
Creator	Abreu, Candida Magro, Fernando Rahier, Jean-François
source	Medline; PMC
abstract	A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for virus spread. Even though research has not evidenced particular susceptibility of inflammatory bowel disease (IBD) patients to SARS-CoV-2 infection, immunosuppressive and immunomodulatory treatments were considered potential risk factors. In this context, initiating treatments with these agents should be cautiously weighted and regular ongoing treatments shall be continued, while the dose of corticosteroids should be reduced whenever possible. Due to the increased risk of contamination, elective endoscopic procedures and surgeries should be postponed and IBD online appointments shall be considered. IBD patients shall also follow the recommendations provided to the general population, such as minimization of contact with infected or suspected patients and to wash hands frequently. In the absence of effective treatments and vaccines, this pandemic can only be controlled through prevention of SARS-CoV-2 transmission with the main objectives of providing patients the best healthcare possible and reduce mortality.
has issue date	2020-04-11(xsd:dateTime)
bibo:doi	10.1177/2050640620920157
bibo:pmid	32281517
has license	cc-by
sha1sum (hex)	0ab46b1df9e05687a789426f9c2d76a56087b072
schema:url	https://doi.org/10.1177/2050640620920157
resource representing a document's title	The daily impact of COVID-19 in gastroenterology
has PubMed Central identifier	PMC7268943
has PubMed identifier	32281517
schema:publication	United European Gastroenterol J
resource representing a document's body	covid:0ab46b1df9e05687a789426f9c2d76a56087b072#body_text
is schema:about of	named entity 'rapidly' named entity 'wash hands' named entity 'regional' named entity 'called' named entity 'strain' named entity '2019' named entity 'corticosteroids' named entity 'virus' named entity 'immunosuppressive' named entity 'INITIATING' named entity 'SITUATION' named entity 'TRANSMISSION' named entity 'RAPIDLY' named entity 'IBD' named entity 'This' named entity 'endoscopic procedures' named entity 'Due' named entity 'reduce' named entity 'immunomodulatory' named entity 'Since' named entity 'infected' named entity 'China' named entity 'prevention' named entity 'surgeries' named entity 'patients' named entity 'contact' named entity 'SARS-CoV-2' named entity 'inflammatory bowel disease' named entity 'immunosuppressive' named entity 'COrona VIrus Disease' named entity 'virus' named entity 'IBD' named entity 'minimization' named entity 'smokers' named entity 'American Society' named entity 'gastrointestinal tract' named entity 'nosocomial' named entity 'antiviral drug' named entity '8 days' named entity 'worldwide epidemic' named entity 'Endoscopy' named entity 'MERS-CoV' named entity 'azithromycin' named entity 'Marburg' named entity 'acute respiratory distress syndrome' named entity 'SARS' named entity 'SARS-CoV-2' named entity 'SARS-CoV' named entity 'ARDS' named entity 'influenza' named entity 'methotrexate' named entity 'endoscopy' named entity 'endoscopy' named entity 'emergency room' named entity 'severe pneumonia' named entity 'ozone' named entity 'liver' named entity 'fever' named entity 'viruses' named entity 'ASGE' named entity 'host cells' named entity 'common cold' named entity 'difficulty in breathing' named entity 'infection' named entity 'virus' named entity 'Betacoronavirus' named entity 'antibody titres' named entity 'PPE' named entity 'epidemic' named entity 'Saudi Arabia' named entity 'airborne route' named entity 'Hand hygiene' named entity 'Remdesivir' named entity 'virus' named entity 'nucleic acid' named entity 'hydroxychloroquine' named entity 'handwashing' named entity 'heart failure' named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software